DXCM — DexCom Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for DexCom, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-Q	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,533	2,708	2,731	2,456	2,724
Net Total Accounts Receivable
Net Total Receivables	286	429	514	713	988
Total Inventory
Prepaid Expenses
Total Current Assets	1,969	3,425	3,684	3,669	4,426
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	393	609	890	1,136	1,185
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	2,395	4,291	4,933	5,392	6,265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	360	614	721	1,839	1,556
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,512	2,464	2,891	3,260	4,196
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	883	1,827	2,042	2,132	2,069
Total Liabilities & Shareholders' Equity	2,395	4,291	4,933	5,392	6,265
Total Common Shares Outstanding